"Hepatitis B e Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
| Descriptor ID |
D006513
|
| MeSH Number(s) |
D23.050.327.495.500.469
|
| Concept/Terms |
Hepatitis B e Antigens- Hepatitis B e Antigens
- Hepatitis Be Antigens
- Antigens, Hepatitis Be
- Be Antigens, Hepatitis
- e Antigens
- Antigens, e
- HBeAg
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B e Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B e Antigens".
This graph shows the total number of publications written about "Hepatitis B e Antigens" by people in this website by year, and whether "Hepatitis B e Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B e Antigens" by people in Profiles.
-
Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Rev Med Virol. 2022 11; 32(6):e2353.
-
Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Aliment Pharmacol Ther. 2019 08; 50(3):306-316.
-
Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Rep. 2016 Nov 15; 2016.
-
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. J Hepatol. 2016 Apr; 64(4):781-9.
-
Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. J Med Virol. 2013 Jun; 85(6):979-86.
-
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012 May; 142(6):1264-1273.e1.
-
Clevudine demonstrates potent antiviral activity in na?ve chronic hepatitis B patients. Intervirology. 2010; 53(2):83-6.
-
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med. 2005 May 17; 142(10):821-31.
-
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology. 2002 Sep; 123(3):719-27.
-
Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway. J Immunol. 2000 Oct 15; 165(8):4581-91.